Functional Studies at GGC

While diagnostic testing often results in a definitive answer for our patients, this testing can sometimes uncover genetic variation whose clinical significance is not clear.  Most of the time, this is because this genetic variation has never been seen or investigated before.   These variants (termed variants of uncertain significance or VUS) require further experimentation to functionally resolve their clinical importance. 

One of the major roles of the GGC’s Research Division is to perform cell- and zebrafish-based functional studies, aimed at determining whether this genetic variation is in fact the cause of the patient’s symptoms.  The value of these types of studies is manifold. First, we can confirm a genetic diagnosis, providing more concrete answers for our patients and their families, and for anyone who encounters the same variant after testing.  Second, as more is understood about the genes being studied, the researchers can look for ways to harness this information towards the development of therapies. Once these studies are complete, the Research team works with the GGC clinicians and genetic counselors to share the information gained.  They also communicate with the GGC Diagnostic directors to see if the variants can be formally reclassified as benign or disease-causing based on current American College of Medical Genetics guidelines.

Since 2018, GGC researchers (in collaboration with others around the world) have studied over 124 variants of uncertain significance in 40 different genes.  These genes express proteins that can be found in all the different parts of the cell (see graphic below).  Functional studies done at GGC have resulted in 10 publications.

Meet Ella

We will remember February 26th for the rest of our lives. On that day, we received the call from the Greenwood Genetic Center that they had discovered our daughter, Ella Marie, has Kleefstra syndrome. Very early on, my wife, Kelly, observed Ella being delayed in some of her milestones. Kelly monitored Ella’s progression and sought out testing in an effort to get Ella some assistance. Along the way, we were sent to GGC and met with Dr. Roger St...

In The News